These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31883086)

  • 1. Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.
    Zhou H; Zhang S; Wang X
    Methods Mol Biol; 2020; 2099():39-50. PubMed ID: 31883086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
    Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein.
    Zhou H; Chen Y; Zhang S; Niu P; Qin K; Jia W; Huang B; Zhang S; Lan J; Zhang L; Tan W; Wang X
    Nat Commun; 2019 Jul; 10(1):3068. PubMed ID: 31296843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
    Zhou Y; Yang Y; Huang J; Jiang S; Du L
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
    Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
    Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors.
    Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
    Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
    mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.
    Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ
    Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26.
    Wang Q; Qi J; Yuan Y; Xuan Y; Han P; Wan Y; Ji W; Li Y; Wu Y; Wang J; Iwamoto A; Woo PC; Yuen KY; Yan J; Lu G; Gao GF
    Cell Host Microbe; 2014 Sep; 16(3):328-37. PubMed ID: 25211075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Evolution of MERS-CoV to Species Variation in DPP4.
    Letko M; Miazgowicz K; McMinn R; Seifert SN; Sola I; Enjuanes L; Carmody A; van Doremalen N; Munster V
    Cell Rep; 2018 Aug; 24(7):1730-1737. PubMed ID: 30110630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.
    Li W; Hulswit RJG; Widjaja I; Raj VS; McBride R; Peng W; Widagdo W; Tortorici MA; van Dieren B; Lang Y; van Lent JWM; Paulson JC; de Haan CAM; de Groot RJ; van Kuppeveld FJM; Haagmans BL; Bosch BJ
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8508-E8517. PubMed ID: 28923942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MERS-CoV spike protein: Targets for vaccines and therapeutics.
    Wang Q; Wong G; Lu G; Yan J; Gao GF
    Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.
    Zhang S; Zhou P; Wang P; Li Y; Jiang L; Jia W; Wang H; Fan A; Wang D; Shi X; Fang X; Hammel M; Wang S; Wang X; Zhang L
    Cell Rep; 2018 Jul; 24(2):441-452. PubMed ID: 29996104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
    Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
    Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.
    Du L; Zhao G; Yang Y; Qiu H; Wang L; Kou Z; Tao X; Yu H; Sun S; Tseng CT; Jiang S; Li F; Zhou Y
    J Virol; 2014 Jun; 88(12):7045-53. PubMed ID: 24719424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus.
    Park D; Huh HJ; Kim YJ; Son DS; Jeon HJ; Im EH; Kim JW; Lee NY; Kang ES; Kang CI; Chung DR; Ahn JH; Peck KR; Choi SS; Kim YJ; Ki CS; Park WY
    Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001214. PubMed ID: 27900364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.